Contribution of CARD15 variants in determining susceptibility to Crohn's disease in Sweden

References

• Satsangi J, Morecroft J, Shah NB, Nimmo E. Genetics of inflammatory bowel disease: scientific and clinical implications. Best Practice Res Clin Gastroenterol 2003; 17: 3–18
   PubMed Web of Science ®Google Scholar
• Lapidus A, Bernell O, Hellers G, Persson PG, Lofberg R. Incidence of Crohn's disease in Stockholm County 1955–1989. Gut 1997; 41: 480–6
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
   PubMed Web of Science ®Google Scholar
• Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, et al. NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869–72
   PubMed Web of Science ®Google Scholar
• Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278: 5509–12
   PubMed Web of Science ®Google Scholar
• Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, et al. NOD2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731–4
   PubMed Web of Science ®Google Scholar
• Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, et al. NOD2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005; 307: 734–8
   PubMed Web of Science ®Google Scholar
• Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800–8
   PubMed Web of Science ®Google Scholar
• Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a meta-analysis. Am J Gastroenterol 2004; 99: 2393–404
   PubMed Web of Science ®Google Scholar
• Helio T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52: 558–62
   PubMed Web of Science ®Google Scholar
• Vind I, Jess T, Riis L, Knudsen E, Dinesen L, Prio T, et al. Incidence of inflammatory bowel disease in Copenhagen 2003–2004: a study from the Danish colitis Crohn database. Gastroenterology 2005; 128(Suppl 2)A328
   PubMed Web of Science ®Google Scholar
• Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes Immun 2004; 5: 417–25
   PubMed Web of Science ®Google Scholar
• Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, et al. Association of NOD2 with Crohn's disease in a homogeneous Irish population. Eur J Hum Genet 2003; 11: 237–44
   PubMed Web of Science ®Google Scholar
• Thjodleifsson B, Sigthorsson G, Cariglia N, Reynisdottir I, Gudbjartsson DF, Kristjansson K, et al. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives?. Gastroenterology 2003; 124: 1728–37
   PubMed Web of Science ®Google Scholar
• Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122: 854–66
   PubMed Web of Science ®Google Scholar
• Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122: 867–74
   PubMed Web of Science ®Google Scholar
• Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925–8
   PubMed Web of Science ®Google Scholar
• Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, et al. Association of NOD2 with Crohn's disease in a homogeneous Irish population. Eur J Hum Genet 2003; 11: 237–44
   PubMed Web of Science ®Google Scholar
• Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype–phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845–57
   PubMed Web of Science ®Google Scholar
• Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123: 679–88
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; Suppl 170:2–6.
   Web of Science ®Google Scholar
• Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8–15
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
   PubMed Web of Science ®Google Scholar
• Schlesselman JJ. Case control studies: design, conduct, analysis, PD Stolley. Oxford University Press, Oxford 1982
   Google Scholar
• Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003; 9: 281–9
   PubMed Web of Science ®Google Scholar
• Heresbach D, Gicquel-Douabin V, Birebent B, D'Halluin PN, Heresbach-Le Berre N, Dreano S, et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype–phenotype analysis. Eur J Gastroenterol Hepatol 2004; 16: 55–62
   PubMed Web of Science ®Google Scholar
• Idestrom M, Rubio C, Granath F, Finkel Y, Hugot JP. CARD15 Mutations are rare in Swedish pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2005; 40: 456–60
   PubMed Web of Science ®Google Scholar
• Buning C, Molnar T, Nagy F, Lonovics J, Weltrich R, Bochow B, et al. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different?. World J Gastroenterol 2005; 11: 407–11
   PubMed Web of Science ®Google Scholar
• Capelli C, Redhead N, Abernethy JK, Gratrix F, Wilson JF, Moen T, et al. A Y chromosome census of the British Isles. Curr Biol 2003; 13: 979–84
   PubMed Web of Science ®Google Scholar